HIGHLIGHTS
- who: Arnaud Del Bello and colleagues from the Department of Nephrology and Organ Transplantation, Toulouse University Hospital, Toulouse, France have published the Article: Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients, in the Journal: Vaccines 2022, 10, 1439. of /2022/
- what: The authors retrospectively analyzed the humoral and cellular responses resulting from a fourth dose of vaccine administered to KTRs having an anti-SARS-CoV-2 antibody titer below 142 binding antibody unit (BAU)/mL at 3 months post-third . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.